Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PfizerfiledCriticalPfizer
Publication of MY105242ApublicationCriticalpatent/MY105242A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
CERTAIN 1-HETEROARYL-3-ACYL-2-OXINDOLES WHEREIN THE ACYL-SUBSTITUENT IS THENOYL, FUROYL, BENZOYL OR SUBSTITUTED BENZOYL, ARE INHIBITORS OF CYCLOXYGENASE AND LIPOXYGENASE ENZYMES AND ARE USEFUL AS ANTI- INFLAMMATORY AGENTS IN MAMMALS.
APPLICATION OF BACTERIA, ASSOCIATED WITH ARGINIDESYMINASE, FOR THE INDUCTION OF APOPTOSIS AND / OR REDUCTION OF INFLAMMATORY REACTION AND PHARMACEUTICAL OR DIETARY COMPOSITIONS CONTAINING SUCH BACTERIA
Succinoylaminohydroxyethylaminosulfonamides, pharmaceutical composition, method of inhibition of retroviral protease, method of treatment of retroviral infection, method of aids treatment